A Drug–drug Interaction Study to Assess the Potential Effect of Acid-Reducing Agent, Lansoprazole, on Quizartinib Pharmacokinetics

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-019-03915-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Simple Method for Evaluation Pharmacokinetics of Glycyrrhetinic Acid and Potential Drug-Drug Interaction Between Herbal Ingredients

Scientific Reports
Multidisciplinary
2019English

A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug–Drug Interactions With Orally Administered Medications

Clinical Pharmacokinetics
Pharmacology
2019English

Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Clinical Cancer Research
Cancer ResearchOncology
2017English

Warfarin Dose Adjustments Due to Drug-Drug Interaction With Dronedarone: A Case-Control Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Clinical Pharmacokinetics of Zanisamide and Drug Interaction With Other Anticonvulsants.

Japanese Journal of Hospital Pharmacy
1994English

Use of Transgenic Mouse Models to Understand the Oral Disposition and Drug-Drug Interaction Potential of Cobimetinib, a MEK Inhibitor

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2015English

Ellagic Acid as a Potential Anti-Cancer Drug

International Journal of Radiology & Radiation Therapy
2017English

Drug-Drug Interaction via Drug Transporters

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Exposure to Potential Drug-Antimicrobial Agent Interactions in Primary Health Care

Vojnosanitetski Pregled
MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy